Loading insider details...
Beta
Latest Form 4 (Apr 22, 2026): Grant/Award of 37,100 ACXP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 22, 2026 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/Award | 37,100 | n/a |
| Feb 6, 2025 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/Award | 250,000 | n/a |
| Jan 8, 2025 | Acurx Pharmaceuticals, Inc. (ACXP) | Purchase | 49,261 | $50.0K |
| Apr 4, 2024 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/Award | 250,000 | n/a |
| Jan 4, 2024 | Acurx Pharmaceuticals, Inc. (ACXP) | Gift | 40,000 | n/a |
| Feb 24, 2023 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/Award | 130,000 | n/a |
| Jul 29, 2022 | Acurx Pharmaceuticals, Inc. (ACXP) | Purchase | 19,737 | $75.0K |
| Nov 22, 2021 | Acurx Pharmaceuticals, Inc. (ACXP) | Purchase | 5,034 | $24.7K |
| Jul 6, 2021 | Acurx Pharmaceuticals, Inc. (ACXP) | Grant/Award | 350,000 | n/a |